SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death

Abstract

The molecular mechanisms underlying the severe lung pathology that occurs during SARS-CoV infections remain incompletely understood. The largest of the SARS-CoV accessory protein open reading frames (SARS 3a) oligomerizes, dynamically inserting into late endosomal, lysosomal, and trans-Golgi-network membranes. While previously implicated in a non-inflammatory apoptotic cell death pathway, here we extend the range of SARS 3a pathophysiologic targets by examining its effects on necrotic cell death pathways. We show that SARS 3a interacts with Receptor Interacting Protein 3 (Rip3), which augments the oligomerization of SARS 3a helping drive necrotic cell death. In addition, by inserting into lysosomal membranes SARS 3a triggers lysosomal damage and dysfunction. Consequently, Transcription Factor EB (TFEB) translocates to the nucleus increasing the transcription of autophagy- and lysosome-related genes. Finally, SARS 3a activates caspase-1 either directly or via an enhanced potassium efflux, which triggers NLRP3 inflammasome assembly. In summary, Rip3-mediated oligomerization of SARS 3a causes necrotic cell death, lysosomal damage, and caspase-1 activation—all likely contributing to the clinical manifestations of SARS-CoV infection.

Cited by papers we hold 15

• SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1 · 2022
  No notice
• SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns · 2021
  No notice
• Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 · 2021
  No notice
• The signal pathways and treatment of cytokine storm in COVID-19 · 2021
  Corrected
• HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19 · 2021
  No notice
• The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors. · 2020
  Not checked
• Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity · 2020
  Not checked
• Targeting the NLRP3 Inflammasome in Severe COVID-19 · 2020
  No notice
• Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 · 2020
  No notice
• Comprehensive mapping of immune perturbations associated with severe COVID-19 · 2020
  No notice
• Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19 · 2020
  No notice
• A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses · 2020
  No notice
• SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes · 2019
  No notice
• A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease Prevention, Novel Drug Design, and Therapy · 2019
  No notice
• Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.